Y Liu, A Leng, L Li, B Yang, S Shen, H Chen… - Cell death & …, 2022 - nature.com
Since its first identification in prostate cancers and prostate tissues, transient receptor potential melastatin-subfamily member 8 (TRPM8) is subsequently found to be …
M Peng, Z Wang, Z Yang, L Tao, Q Liu… - Oncology …, 2015 - spandidos-publications.com
The aim of the present study was to investigate the function of a transient receptor potential melastatin 8 (TRPM8) splice variant, short TRMP8α (sM8α), in the androgen‑dependent …
GP Grolez, DV Gordiendko, M Clarisse… - Cell death & …, 2019 - nature.com
In prostate carcinogenesis, androgens are known to control the expression of the transient receptor potential melastatin 8 (TRPM8) protein via activation of androgen receptor (AR) …
GP Grolez, D Gkika - Pharmaceuticals, 2016 - mdpi.com
Prostate cancer (PCa) is one of the most frequently diagnosed cancers in developed countries. Several studies suggest that variations in calcium homeostasis are involved in …
Y Sui, S Li, Y Zhao, Q Liu, Y Qiao, L Feng, S Li - Fitoterapia, 2020 - Elsevier
Transient receptor potential melastatin 8 (TRPM8) is a calcium ion-permeable cation channel that is used as a prognostic marker and therapeutic target for different tumor types …
Y Wang, Z Yang, Z Meng, H Cao, G Zhu… - … Journal of Biological …, 2014 - ncbi.nlm.nih.gov
As the function of transient receptor potential melastatin member 8 (TRPM8) in osteosarcoma is still unknown, we aim to investigate the possible effects and potential …
A Borgström, C Peinelt, P Stokłosa - Biomolecules, 2021 - mdpi.com
Transient receptor potential melastatin 4 (TRPM4) is widely expressed in various organs and associated with cardiovascular and immune diseases. Lately, the interest in studies on …
S Genovesi, R Moro, B Vignoli, D De Felice… - Biomolecules, 2022 - mdpi.com
Metastatic prostate cancer (mPCa) is one of the leading causes of cancer-related mortality in both the US and Europe. Androgen deprivation is the first-line therapy for mPCa; however …
A Borgstroem, B Hauert, S Kappel, E Zoni… - Journal of molecular …, 2021 - Elsevier
Transient receptor potential melastatin 4 (TRPM4) is a broadly expressed Ca 2+ activated monovalent cation channel that contributes to the pathophysiology of several diseases. For …